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Crystal toxins from Bacillus thuringiensis bind to glycolipids and glycoproteins using two different lectin
domains in the toxin protein. Our previous observations suggested that the sequestration of crystal
toxin depends on the functional interaction of a toxin lectin with glycolipids. Given the ﬁnding that
competition of a galectin LEC-8 with Cry5B for binding to glycolipids resulting in reduced Bt toxicity in
nematode, it is interesting to explore the role of LEC-8 in insects. Here, we reported that the LEC-8 can
also be exploited by insect for their survival when they were fed with Bt toxin food. Bioassay with
LEC-8 showed that pre-feeding of Helicoverpa armigera larvae reduced the Cry1Ac susceptibility. Both
LEC-8 and Cry1Ac bind to the midgut glycolipid in a similar way. Further ELISA indicated that LEC-8
interacts with glycolipid from insect midgut, thus reduce Cry1Ac binding to glycolipid. This in turn
enhances insect tolerance to Cry1Ac toxin. The sugar determinants of LEC-8 were studied by using
haemagglutination (HA) and haemagglutination inhibition (HAI) assay. It was suggested that the
terminal sugar of LEC-8 has multiple sugar binding property.
Crown Copyright & 2012 Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Crystal toxins from Bacillus thuringiensis (Bt) are widely used
for insect pest control in the forms of transgenic crops and spray
formulations. However, the detailed mode of action of Bt toxin
remains fragmented [5]. In the current models, the domain III [6]
of Bt toxin will bind to the GalNAc containing glycoproteins
receptors on the brush border membrane (BBM) [17] followed
by insertion into the BBM as a tetrameric pre-pore complex [10].
However, it is difﬁcult to explain how water-soluble toxin inserts
into the membrane by solely using receptor-bound model. In fact,
some ﬁndings suggested that other components might also
contribute the insertion of pre-pore toxin into the membrane. It
is noticeable that glycolipids from nematode were demonstrated
to be receptors for Bt (Cry5B and Cry1A) toxin [11].
To uncover the mechanism behind the interaction of glycolipid,
Ideo et al. proved that a galectin-LEC-8 from nematode gut protect
the nematode from bacterial infection [14]. They reported that LEC-82sevier B.V.
BR250, Coomassie Brilliant
glycolipid; HAI, haemagglu-
yer chromatograph; PIBM,
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Open access under CC BY-Ncan bind to the same major glycolipids as that of Cry5B, and compete
with Cry5B for binding to glycolipid, and enhance Bt resistance in
nematode. The major characteristics of the galectins are that they
have evolutionarily conserved carbohydrate recognition domain
(CRD) and have b-galactoside-binding activity. LEC-8 from nematode
is a novel chimera type galectin-like protein since it has an N-term-
inal CRD and an unknown functional region at the C-terminal [25].
Given that glycolipids from Manduca sexta could also be used the
glycolipid as receptors for Cry1A toxins [11], and the 24% sequence
identity in the three domains of the nematode speciﬁc Bt toxin Cry5B
and the lepidopteran speciﬁc Bt toxin Cry1A, the implication from
these ﬁndings is that glycolipids in insect might also play an
important role for the interaction with water soluble toxin.
Glycolipid in insect also existed in the lipid carrier lipophorin.
The lipid carrier lipophorin is an important component of cell-free
defence reactions having a dual role in lipid metabolism and in
immunity as a pro-coagulant [21]. It can be induced by immune
elicitors [8] and is transported into the gut lumen in the presence
of toxin [32], where it can become involved in aggregation
reactions that can inactivate the toxin before it can reach the
brush border membrane. A defence mechanism that allows
insects to tolerate low to medium levels of endotoxin from
B. thuringiensis [22,23,30] has been deﬁned by using the induction
of immune and metabolic components that inactivate the toxin
inside the gut lumen via a cell-free defence reaction [31].
While it is known that the lectin function in Domain III interacts
with glycoproteins on the brush border membrane [6], the putativeC-ND license.
Fig. 1. SDS-PAGE and Western blot analysis of Cry1Ac toxin and LEC-8. Arrows
indicated the proteins of interest. (A) Solubilisation and activation of Cry1Ac
protoxin in sodium carbonate buffer. Pro: solubilised Cry1Ac protoxin (135 kDa) in
sodium carbonate buffer; Act: tryptic-active Cry1Ac toxin (65 kDa) in sodium
carbonate buffer. (B) Expressed and puriﬁed LEC-8. The predicted size for LEC-8 is
20 kDa. Combined with the GST-tag from pGEX6p1 vector, the expressed protein
is about 46 kDa in size. Lane 1 is the expressed LEC-8 stained with anti-LEC-8
antibodies, and lane 2 is the expressed LEC-8 stained with CBBR-250 stain.
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glycolipids [20]. A recombinant M-peptide representing Domain II in
Cry1Ac binds to insect glycolipids. Moreover, the M-peptide, as well
as the mature Cry1Ac toxin can interact with glycolipids by forming
a tetrameric complex that has the potential to aggregate glycolipid-
containing lipoproteins, such as lipophorin. This was conﬁrmed by
using low-density puriﬁed lipid particles and to demonstrate the
formation of large aggregates in the presence of mature toxin or
Domain II peptides [20]. These data suggest that the sequestration of
toxin in the gut depends on the functional interaction of a toxin
lectin with glycolipids of the pro-coagulant lipophorin toxin. But
how the insect glycolipids interact with Cry1Ac remains elusive.
Involvement of galectin in Bt resistance in nematode [14] shed
light for studying the interaction of glycolipid with Bt toxin from
insect. As glycolipid binding proteins, galectins were mainly
involved in cell adhesion and took part in the immune reaction
[16,26,28]. Our previous observations suggested that an additional
trigger of toxin oligomerisation by glycolipid can lead to tolerance to
toxin in insect [20]. Given the inducible capability of LEC-8 after
bacterial infection [24], it is interesting to explore the role of LEC-8
in insects and its effect on Bt toxin in lepidopteran, which comprise
some of the most damaging insect pests in agricultural production.
Although the LEC-8 was not native to insect, it might have potential
role in insect Bt tolerance just like the mammalian galectin (LEC-1)
[7] could be involved in Bt toxicity in insect.
In the current study, we reported the involvement of LEC-8 in
insect tolerance by feeding insect larvae with LEC-8 and examined
the susceptibility to subsequently applied Bt toxin (Cry1Ac). The
binding of LEC-8 to glycolipids, and the interaction of LEC-8 and
glycolipids with Cry1Ac toxin were further studied. The terminal
structure of the glycolipid from Helicoverpa armigera was deduced
by using haemagglutination inhibition (HAI) assay. We found LEC-8
also played an important role in Cry1Ac tolerance from insect.2. Materials and methods
2.1. Bt-endotoxin crystal solubilisation and activation
The HD-73 Bt strain contains a plasmid that produces Cry1Ac
as the only crystal d-endotoxin. Cry1Ac Bt pro-toxin was prepared
and puriﬁed as described by Ref. [18]. The method proposed by
Ref. [6] was used for solubilisation of the Cry1Ac d-endotoxin
crystal. The solubilised and active Cry1Ac toxin (Fig. 1A) was used
for the current studies.2.2. Expression and puriﬁcation of LEC-8
LEC-8 was expressed in E. coli by using an expression construct
in pGEX-6p1, which was a kind gift from Dr Yamashita, Japan. The
protein was expressed according to the method of Ref. [14].
The expressed LEC-8 was puriﬁed with glutathione super ﬂow
(Qiagen) essentially based on the manufactures’ method. The
predicted size is 20 kDa plus a 26 kDa GST tag. The expressed
protein was around 46 kDa (Fig. 1B).2.3. Protein concentration, SDS-PAGE and Western blots
The concentration of the activated toxin and the proteins of
interest were determined by the method of Bradford. The proteins
were separated by SDS-PAGE. After gel electrophoresis; the
proteins were transferred to nitrocellulose membrane (Western
blot) in the Towbin transfer buffer for protein identiﬁcation by
antibody detection.2.4. Production of polyclonal antibody against LEC-8
Puriﬁed LEC-8 was run on 12.5% SDS-PAGE. After electrophoresis,
the gel was rinsed with water, followed by staining with 0.05%
Coomassie Brilliant Blue R250 (CBB250) in water for 10 min, then
destained with water. The protein band was cut and sent to the
Institute of Medical and Veterinary Science (IMVS), South Australia,
Australia, for polyclonal antibodies production based on the stan-
dard method. In brief, the bands from gel were homogenised in PBS,
pH 7.4 buffered saline, pH 7.4 and the complete Freund’s adjuvant.
After ﬁrst injection with the antigen, three additional boost injec-
tions were performed with the antigen in incomplete Freund’s
adjuvant. The titre and quality were tested (results not shown).
2.5. Insect bioassay with LEC-8 and Cry1Ac
To test whether bacteria expressed LEC-8 has a similar role in
insect tolerance to Cry1Ac s-endotoxin as that in nematode,
100 ml of LEC-8 at a dose of 10 ng/ml PBS, pH 7.4 was surface applied
on one ml H. armigera food. The H. armigera culture ‘‘ANGR’’ was used
in the current study. It was originally from CSIRO Australia [2] and
reared in the lab for several generations [29]. Larval growth condi-
tions were the same as that of Ref. [29]. Cell lysates from empty
vector and PBS treated only were used as negative controls. Insect
larvae with an initial weight of 20 mg were used for bioassay. Two
days after feeding with the food mixture, the larvae were transferred
to trays with one ml fresh food contaminated with or without
0.01 mg/ml Cry1Ac. Bioassay was repeated thrice for each treatment,
and each replicated contained 10 larvae. Bioassay experiment was
performed for 9 d after application of Cry1Ac toxin. Larval weight was
monitored daily and expressed as mean larval weight (mg)7stan-
dard error. Since the most signiﬁcant difference between the four
treatments was the larval weight, the larval weight was used to
assess the competition experiment. Data were analysed by using
repeated measures (mixed model) ANOVA approach by using Graph-
Pad Prism version 5.00 for Windows, GraphPad Software, San Diego
California USA, http://www.graphpad.com. Bonferroni post-tests were
used to compare replicated means.
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tolerance, the following two treatments were performed. Larvae
treated with the food containing ‘‘100 ml of LEC-8 at a dose of
10 ng/ml and 0.01 mg/ml Cry1Ac in PBS’’, and 100 mM of lactose
then ‘‘LEC-8þCry1Ac’’. The weight of individual larva was mea-
sured on the ninth day. The growth and treatment conditions and
data analysis were the same as above.
2.6. HPTLC overlay analysis
To test whether LEC-8 binds to glycolipid from insect in vitro, the
glycolipid frommidgut tissues of the same H. armiger population [20]
at fourth to ﬁfth instar stage were used for neutral glycolipids
extraction essentially based on the method of Refs. [4,20]. The
glycolipids was puriﬁed with a Sep-Pakþcartridge (C18, Water) and
dried under a stream of nitrogen at a 42 1C heat block. The dried
glycolipids were resuspended into one-half volume of ethanol. 7.5 ml
of glycolipids from H. armigera was applied on the HPTLC plate
(Merck aluminium backed silica-60 high performance thin layer
chromatograph plate). The glycolipids were developed in methanol:
chloroform:water (4:4:1) for about 15min. The plate was then
stained with orcinol–sulphuric acid–methanol solution by a colour
reaction after heating at 125 1C. After ﬁxation with 0.02% polyisobu-
tylmethacrylate (PIBM) in hexane solvent (90% hexane with 10%
chloroform, v/v) for 1 min, the HPTLC was blocked with 0.5% bovine
serum albumin (BSA) in PBS (137mMNaCl, 10mM Phosphate buffer,
2.7 mMKCl, and a pH of 7.4) with 0.02% tween-20 for 30 min at room
temperature. About 22 nM of LEC-8 in 10ml of PBS buffer (0.5% BSA,
pH 7.4) was overlaid with the plate for two hours at room
temperature (about 20 1C). The plate was washed with PBST for four
times and incubated with antibodies against LEC-8 in a ratio of
1:1000 overnight. After washing with PBST for four times, the plate
was incubated with antibodies anti-Rabbit IgG conjugated with
alkaline phosphatase in a ratio of 1:1000 for two hours. After washing
with PBST for four times, the HPTLC overlay was detected by a colour
reaction in an alkaline buffer with NBT and BCIP as substrates.
To further assess whether pre-incubation with LEC-8 can
reduce or inhibit the binding of Cry1Ac to glycolipid, after HPTLC
resolution the glycolipid was ﬁrst incubated with 22 nM of LEC-8
for 2 h at 20 1C before incubation with 20 nM Cry1Ac for 2 h. The
plate was then incubated with antibodies against Cry1Ac for
overnight and the second antibodies for 2 h and developed by
using the same method as above.
2.7. Competition between Cry1Ac and LEC-8 or sugars for glycolipid
binding
To test whether binding of LEC-8 to insect glycolipids inhibit the
glycolipids binding to Cry1Ac, an in vitro competition experiment
was performed based on the method of Refs. [4,11] with some
modiﬁcations. In brief, the Nunc Polysorp 96-well ﬂat microplate
was equilibrated with 25 ml of methanol. The plate was dried at
room temperature followed by application of 7.5 ml gut glycolipids.
The plate was then left at room temperature for completely drying
followed by blocking the wells with 100 ml of 0.5% BSA in PBS buffer
for 300 at RT. Three treatments with three replicates were per-
formed: LEC-8 only (concentration from 0 to 140 nM), active Cry1Ac
only (concentration from 0 to 140 nM) and the mixture of 20 nM
Cry1Ac and variable LEC-8 (from 0 to 900 nM). The three treatments
at various concentrations in 100 ml PBS were incubated with
glycolipids for two hours at room temperature. After washing four
times with 200 ml of PBS, the plate was incubated with 100 ml of the
ﬁrst antibodies (anti-Cry1Ac for treatments Cry1Ac and mixture of
LEC-8 with Cry1Ac, anti-LEC-8 for treatments LEC-8) at 1:1000 for
one hour at room temperature. After washing four times with 200 ml
of PBS, the plate was incubated with 100 ml of the second antibodies(anti-IgG conjugated with alkaline phosphatase) at 1:1000 for one
hour at room temperature. The plate was washed four times with
200 ml of PBS, and incubated with 100 ml of alkaline phosphatase
yellow liquid substrate system for ELISA (pNPP) for 10 min at room
temperature before measuring the OD405 with AccuReader (Meter-
tech Inc.). The absorbance value was determined by subtracting the
value obtained from the control. Data points were mean values from
three experiments, and the error bars denoted as S.E.M.
2.8. Haemagglutination (HA) assay and haemagglutination
inhibition (HAI) test
To test whether that LEC-8 has the lectin activity, Sheep Red
Blood Cells (SRBCs) from Sigma were resuspended in PBS to a ﬁnal
concentration of 2% (v/v) with 0.5% BSA according to the method
of Ref. [1] with some modiﬁcations. The assay was carried out at
37 1C with a Libro 96-well U shape microplate (Flow laboratories,
Inc. USA). 50 ml of PBS with 0.25% BSA was added to each well.
50 ml of LEC-8 was applied in a series two fold diluted solution
with PBS with 0.5% BSA. Lastly, 50 ml of 2% SRBC in PBSþ0.25%
BSA was added to each well. The HA activity was determined after
incubation for one hour at 37 1C. The degree of lectin activity of
LEC-8 was graded based on Ref. [1] as high, an even carpet of
erythrocytes covering the bottom of the wells; moderate, an even
carpet with a ring at the edge; and low/non-active, a small ring or
a complete button.
To determine the possible terminal structure speciﬁcity of
LEC-8, twelve saccharides (Fig. 5) at a concentration of 100 mM
was examined for their inhibitory effect on HA activity of the
puriﬁed LEC-8. The HAI activity was expressed as three types: the
sugar that completely, partially and does not inhibit the aggluti-
nation. Based on above HAI experiments, to further test sugar
effect on LEC-8 binding to insect glycolipids, four different sugars
(lactose, galactose, GalNac and Glucose, which represent three
types of sugars with different inhibition effect) at various con-
centrations (from 0 to 100 mM) were used for inhibitory experi-
ment by using the method as in experimental procedures.3. Results
3.1. Pre-feeding H. armigera with LEC-8 reduces its susceptibility
to Cry1Ac
To test whether the LEC-8 has protection effect on Cry1Ac in
H. armigera, the larvae were subjected to four treatments (see
method Section 2.5). After bioassay, statistical analysis was
performed by using mixed model ANOVA approach. There is a
highly signiﬁcant difference for days after treatment among four
treatments, and the interaction between the day after treatment
and treatment. The day after treatment was the major effector,
and its effect was extremely signiﬁcant (73%, Po0.0001). The
interaction between treatment and time was highly signiﬁcant
(14%, Po0.0001). No signiﬁcant difference was found among the
four treatments before the fourth day after initiation of the Cry1Ac
treatments. But the difference becomes more and more signiﬁcant
at day four and the trend sustained in the rest of the experiment
period. A highly signiﬁcant difference was observed between pre-
treatment with extracts from empty vector (BL) followed by Cry1Ac
and the other three treatments. From day 4 onwards, when the
growth of the insect larvae was measured by using the larval weight,
the growth of insect larvae was signiﬁcantly inhibited under the
treatment of extract from empty vector followed by Cry1Ac. Under
this condition, the insect larval weight increased only two folds from
day four to day nine. On the other hand, the larval weight of the
other three treatments increased from four to ﬁve folds. It was also
Fig. 2. (A) Pre-feeding LEC-8 reduces toxicity of Cry1Ac toxin in Helicoverpa
armigera. There were four treatments: empty vector (BL), empty vector then
Cry1Ac (BLþCry1Ac), LEC-8, and LEC-8 then Cry1Ac (LEC-8þCry1Ac). Three
replicates (10 larvae per replicates) were performed. Larval weight was monitored
at day 1, day 2, day 3, day 4, day 5, day 7 and day 9, and expressed as in mean
weight (mg)7standard error. Larval weight was used for statistical analysis by
using mixed model ANOVA. Bonferroni post-tests were used to compare replicate
means. (B) Pre-feeding lactose then LEC-8 and Cry1Ac increase the Cry1Ac
toxicity, compared with the treatment of LEC-8 and Cry1Ac.
Fig. 3. (A) Orcinol stain and HPTLC overlay of the glycolipids (upper phase) from
midgut tissues of H. armigera with Cry1Ac and recombinant LEC-8. Two arrows
indicated the glycolipids of longer chain oligosaccharides after staining with
orcinol. It showed there was no difference for LEC-8 and Cry1Ac binding to the
glycolipids. Sd, neutral glycolipid standard: 1, cerebroside (Gal-ceramide); 2,
Lactosylceramide; 3, Globotriaosyl-ceramide; 4, globoside. Arrow head indicate
the initial loading lane. (B) Pre-incubation of glycolipid with LEC-8 (L) reduced the
binding of Cry1Ac (C) to glycolipid.
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all the four treatments, but was not signiﬁcant (Fig. 2A). There was
no signiﬁcance difference between (LEC-8þCry1Ac) and LEC-8
treatments under the experiment conditions during most of the
experimental period.
In the second bioassay experiment, we observed that when the
larvae were pre-fed with 100 mM lactose, then LEC-8 and Cry1Ac,
the tolerance of the insect larvae reduced about 24% (indicated by
reduced larval weight), compared with those treated with LEC-8
and Cry1Ac. This indicated that pre-treatment with lactose could
increase the susceptibility of insect larvae to Cry1Ac toxin at day
9 (Fig. 2B).
3.2. LEC-8 reduce the binding of Cry1Ac to glycolipid
Since pre-feeding LEC-8 reduces the toxicity of Cry1Ac to
H. armigera larvae, and Cry1Ac toxin was found to interact with
insect glycolipids [20], we tested whether LEC-8 also binds to
insect glycolipids in a similar way just as the case in nematode
[11]. Based on the orcinol staining result, there were at least
seven bands stained with orcinol. There were two bands around
the areas where glycolipids with long chain oligosaccharides
positioned (Fig. 3A, arrows). After overlay with LEC-8 and Cry1Ac,it was found that both bind to the glycolipids in the same
oligosaccharides’ areas. However, it was also noticed that neither
LEC-8 (arrows in Fig. 3A) nor Cry1Ac [20] binds to those
glycolipids.
To further test the effect of LEC-8 on the Cry1Ac binding to
glycolipid, the HPTLC plate was pre incubated with LEC-8, then
overlaid with Cry1Ac. We found that the binding capacity of the
Cry1Ac was decreased in certain degree (Fig. 3B).3.3. Inhibition of LEC-8 on Cry1Ac binding to glycolipids
Given both LEC-8 and Cry1Ac bind to glycolipids in a similar
way, and pre-incubation of HPTLC with LEC-8 could reduce the
binding of Cry1Ac to the glycolipids on the plate, a microplate
method was used to investigate whether the reduced suscept-
ibility to Cry1Ac after pre-feeding with LEC-8 was related to the
inhibition effect of LEC-8 on Cry1Ac binding to glycolipids. The
binding property of both Cry1Ac and LEC-8 could bind to
glycolipids in a concentration-dependent manner (Fig. 4A and B).
Comparing with Cry1Ac, the binding of LEC-8 to glycolipids was
about one ﬁfth of the absorbance value when both at the highest
concentration (140 nM). When the mixture of 20 nM Cry1Ac and
various concentration of LEC-8 were incubated with glycolipids, the
binding of Cry1Ac to glycolipids were gradually decreased along
with the increased ratio of LEC-8 over Cry1Ac (Fig. 4C). The
inhibition effect reached to a maximum 30% of decline even the
concentration of LEC-8 reached to 500 nM.
Fig. 4. Competition of LEC-8 and Cry1Ac for binding to glycolipids from gut tissues by using the ELISA method. Four binding experiments were performed, and the results
were expressed as either absorbance value at 405 nm or relative activity (%). (A) Binding of LEC-8 to Glycolipids from gut tissue. (B) Binding of Cry1Ac toxin to Glycolipids
from gut tissue. (C) Inhibition effect of LEC-8 on 20 nM Cry1Ac binding to Glycolipids from gut tissues. (D) Inhibition of four sugars (beta lactose, galactose, N-acetyl
galactosamine and glucose) on the binding of 40 nM LEC-8 to Glycolipids from midgut tissue. Detailed experimental protocol was in Section 2.7.
Fig. 5. Haemagglutination assay and Haemagglutination inhibition test of recom-
binant LEC-8. A: Haemagglutination assay of LEC-8. Concentration of LEC-8 was
expressed as fold of the initial concentration. B: Haemagglutination inhibition test
of LEC-8. 12 different sugars at concentration of 100 mM were used in this
experiment. 1: lactose; 2: galactose; 3: GalNAc; 4: sorbitol; 5: mannopyranose; 6;
mannoheptose; 7: inositol; 8; mannose; 9; xylose; 10: rhamonose; 11: trehalose;
12: glucose.
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To further test the sugar terminal component, HA and HAI
were performed. After incubation with sheep red blood cells
(SRBCs), LEC-8 was found to have lectin effect on SRBCs. Lectin
activity of LEC-8 was obtained at a concentration of 50 ng/ml
based on the criteria in experimental procedures. LEC-8 has a
minor effect on heamagglutination of SRBCs at a concentration of
25 ng/ml, which is indicated by the fussy spreading of SRBCs.
Further reducing the concentration of LEC-8 had no visible lectin
activity (Fig. 5A). To further test the sugar binding speciﬁcity of
LEC-8, 12 different sugars were used for HAI assay. After incuba-
tion, it was observed that three different types of lectin properties
were found based on the method in experimental procedures.
The ﬁrst type is 100 mM lactose had the high inhibition effect on
the lectin activity of LEC-8. The second type had a moderate
inhibition effect on the lectin activity of LEC-8 comparing with
the ﬁrst type. This second type includes GalNAc, galactose,
mannopyranose, inositol and trehalose. The third type had no
inhibition effect on lectin activity, including sorbitol, mannohep-
tose, mannose, xylose, rhamonose and glucose (Fig. 5B).
Since sugar has inhibition effect on lectin activity of LEC-8, we
then quantitatively tested sugars effect with four different sugars:
lactose, GalNAc, galactose, and glucose (which are representative
of three types of inhibition effect sugar). Results from the
inhibition experiment by ELISA were almost consistent with the
HAI result. But lactose has the highest inhibition effect, and it can
reduce the binding of LEC-8 to glycolipids by a maximum 20%. On
the other hand, glucose has no effect on LEC-8 binding under the
current condition. The effects of GalNAc and galactose were just
in the between (Fig. 4D).4. Discussion
Here, we reported the protection role of LEC-8 on the insect
survival when they were fed with Cry1Ac toxin. LEC-8 was
demonstrated to be involved in Cry5B resistance in nematode
by competing with Cry5B toxin for glycolipid binding [14]. The
current bioassay result showed that LEC-8 also plays an immune
reaction role for insect Bt tolerance. Since insect tolerance to the
crystal toxin Cry1Ac is mediated by the binding of a monomeric
toxin to lipophorin glycolipids causing oligomerization and
sequestration reactions [20], it is envisaged that the adhesion
molecule LEC-8 is involved in the interaction with glycolipids
thus affect the Cry1Ac toxicity to insect. To test the interactions,
HPTLC and ELISA methods were used. LEC-8 binding result from
HPTLC showed that it binds to glycolipids from gut tissue in a
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also interesting to note that two glycolipids from H. armigerawith
long-oligosaccharide chain could be stained with orcinol. But
neither Cry1Ac nor LEC-8 binds to them. One possible explanation
is that there might be a third party protein, which may act as
receptors for LEC-8 and can interact with the lipophorin glycoli-
pids [20]. Potentially, other proteins from insect might have
similar role like galectin binding protein (Gal3-BP) from human
involved in the formation of microparticles (MP) which led to the
platelet coagulation and the venous thrombosis [9]. The binding
ability of LEC-8 to the assumed proteins might be due to the
uncharacterised C-terminal domains [25]. Further study in this
area is needed.
To further address the inhibition effect of LEC-8 on the binding
of Cry1Ac to glycolipids, we incubated the LEC-8 with Cry1Ac at
different ratios. ELISA result indicated that binding of Cry1Ac to
glycolipids was decreased along with the increase of LEC-8
concentration. Compared with the maximum inhibition effect of
30% on Cry1Ac binding to glycolipids, a signiﬁcant larval weight
gaining from the immune protection role of LEC-8 might be due to
the synergistic effect of LEC-8 with other binding proteins [9]. We
also tested the inhibition effect of LEC-8 by using HPTLC; we
found that binding of LEC-8 to glycolipid could reduce the binding
of Cry1Ac with glycolipid. Consistent with the ELISA and HPTLC
results, insect bioassay also conﬁrmed that the LEC-8 had a
certain inhibition effect.
It is also known that galectins have diverse functions based on
their structure properties. For example, in contrast to the immune
protection role of LEC-8, a galectin from mammal (LEC-1) pos-
sesses immunosuppressive property. LEC-1 had insecticidal effect
against diamondback moth via affecting the integrity of chitin
structure on peritrophic membrane [7]. Why LEC-1 have different
effect towards insect whereas LEC-8 has contrast protection role
for insect from Cry1Ac intoxication? One possible explanation is
that they have different structural conformation [13]. Since LEC-8
from nematode is a novel chimera type galectin-like protein [25].
It can potentially bind to sugars from the terminal of glycolipids
or glycoproteins. Whereas LEC-1 is a prototype thus it has
different property. This might be one major reason for their
different functions towards insects. In addition, this also sug-
gested that structure, and especially, the terminal sugar binding
property of galectin affects its functional role.
To further understand the molecular mechanism behind the
protection role of LEC-8 from Cry1Ac, we determined its terminal
sugar binding property by using HA and HAI methods. By using
SRBC and ELISA, we showed that LEC-8 has multiple sugar binding
activity: including lactose, GalNAc, galactose, mannopyranose,
and inositol and trehalose speciﬁc lectin activity. It is well known
that domain III from Bt crystal endotoxin has the GalNAc speciﬁc
binding property to receptors such as amino peptidase (APN) on
the BBMV [6]. We previously found that Domain II has lectin
activity, which binding to glycolipids derived from liporphorin or
gut tissues [20]. Both LEC-8 and Cry1Ac [20] could bind to more
than two glycolipid bands. Given that LEC-8 has multiple binding
activities, it is possible LEC-8 may take advantage of the multiple
binding activities to bind to different glycolipids which has
different terminal speciﬁcity. By doing so, the LEC-8 might
compete with Domain II for binding to insect glycolipids. This
assumption was supported by studies that the b-prism motifs
from Domain II of Cry1Ac, Jacalin and MOV-I have structure
similarity (Jose´ Ce´sar [15]) though with very low sequence
similarity. Domain II is also similar to banana lectin in structure,
which has two carbohydrate binding sites [27]. These lectins have
galactose or mannose binding speciﬁcity. The ﬁnding that pre-
feeding LEC-8 enhanced the tolerance of H. armigera also reﬂected
the observation that GalNAc pre-treatment inhibits trapping of BtCry1Ac on peritrophic membrane of Bombyx mori [12]. In addi-
tion, the current ﬁndings that trehalose is one terminal sugar
suggested that this sugar might also involve in the regulation of
immune reaction against bacterial infections by regulation of
lipophorin transportation [19]. Based on the current and previous
ﬁnding [20], a model for Cry1Ac tolerance in insect is proposed.
The hypothesis is that if LEC-8 has similar role in insect tolerance
as in nematode resistance, after feeding the wild type strain with
LEC-8, the LEC-8 will ﬁrst bind to glycolipid from insect, and
reduce binding of Cry1Ac toxin to glycolipid, thus the toxicity of
Cry1Ac to wild type insect will be reduced. Given a receptor for
galectin from human is a component for human microparticle
(MP), which involved in the platelet aggregation [3,9,33], similar
role might have happened in insect when the insect was immune
induced by elicitors from Bt toxin. The ﬁnding that pre-feeding
LEC-8 can elevate Cry1Ac tolerance in the wild type H. armigera
has an implication for Bt tolerance management. The importance
of the study is that glycolipids play an important role in Bt toxin
binding and tolerance. Once the status of insect glycolipids
changed, it will affect Bt tolerance. Immune induced tolerance is
associated with insect metabolism [29], in which glycolipids
status might be changed during its physiological development
and under immune challenge. This in turn could lead to the
development of Bt tolerance in insect.Acknowledgements
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